| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_006e91eddabe95ad7aa889123d31cb9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3cdf812bf3b65fbc415d7656028e71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_789e84a5917ce276c4eb5e929b7a4a57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c5bdcd51aa2209902a69f3271ab00e0 |
| publicationDate |
2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016036861-A1 |
| titleOfInvention |
Methods for formulating antibody drug conjugate compositions |
| abstract |
The present invention provides improved methods for formulating therapeutic compositions comprising an antibody drug conjugate ("ADC") that reduce potency variability between batches of ADC and provide for administration of such therapeutic compositions within a narrow intended range. The current invention provides a novel method for formulating a therapeutic composition comprising an antibody drug conjugate ("ADC") based on drug concentration, thereby narrowing variability in potency between batches of ADC, minimizing toxicity and increasing the efficacy of drug formulated according to this method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10822313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898579-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11572349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3769787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017004025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10494348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478553-B2 |
| priorityDate |
2014-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |